Dupilumab treatment outcomes in bullous pemphigoid: a systematic review and single-arm meta-analysis
{{output}}
Background: Bullous pemphigoid (BP) is the most common autoimmune subepidermal bullous disease of the skin. Novel biologic agents represent a potential therapeutic option. We explore the use of dupilumab in the treatment of BP. ... ...
